Laser Interstitial Thermal Therapy (LITT) in Epilepsy Surgery

Status: draft · Last updated 2026-11-17 · By Jason S. Hauptman, MD, PhD (AI-assisted)

Read in the interactive book →

High-yield points

  • LITT vs. open surgery:
    • What LITT offers: a minimally invasive approach, a 1–3-day stay and fewer complications (18% vs. 30%).
    • The cost: somewhat lower seizure freedom (54% vs. 68%), especially in children and extratemporal epilepsy .
    • Failure isn't final: it doesn't preclude open surgery.
  • MTLE:
    • Engel I: about 50–60% (about 60% with MTS, and up to 90% in a small pediatric MTS series).
    • Durability: 49% at about 4 years .
    • Cognition: better naming and memory than open resection .
    • Targeting: ablate the amygdala and anterior hippocampus.
    • After failure: ATL rescues two-thirds .
    • SLATE (prospective pivotal trial, adults): 56% Engel I at 12 months, 7.9% qualifying adverse events, and naming and verbal memory preserved .
  • Hypothalamic hamartoma:
    • LITT is first-line, with seizure freedom about 75% .
    • Strategy: disconnect the attachment and stage large lesions .
    • Risks: memory and endocrine effects.
  • Callosotomy:
    • LITT matches open surgery for drop attacks (about 50% drop-free).
    • Hospital stay: 2 vs. 6 days.
    • Downside: more re-operations.
    • Keep it to 1–2 trajectories .
  • Lesional:
    • FCD II and TSC: results similar to resection .
    • Cavernoma: 82% Engel I, with no hemorrhage .
    • PVNH: 80% if unilateral .
    • Use SEEG to define the target when the anatomy doesn't .

Landmark papers

  • SLATE (Visualase pivotal trial; ClinicalTrials.gov results 2025): the first prospective multicenter trial of laser amygdalohippocampotomy for mesial temporal lobe epilepsy (adults). It gave 56% Engel I at 12 months with preserved naming and verbal memory .

MR-guided laser interstitial thermal therapy (LITT; also MRgLITT or stereotactic laser ablation, SLA) works through a small skull bolt:

Jason S. Hauptman, MD, PhD© 2026 Jason S. Hauptman, MD, PhD. All rights reserved. Original figure from Hauptman's High Yield Thoughts in Pediatric Neurosurgery (pedsneurosurg.org). Do not copy, reproduce, redistribute or adapt without written permission.https://www.pedsneurosurg.org/hy-peds-ns:litt_epilepsy:00a59da1245e5e6e© 2026 Jason S. Hauptman, MD, PhD. All rights reserved. Original figure; please do not copy, reproduce or redistribute without written permission.Laser interstitial thermal therapy in epilepsy: amygdalohippocampotomy along the hippocampal axis from an occipital entry, disconnection of a hypothalamic hamartoma at its attachment, ablation of the anterior two-thirds of the corpus callosum, and ablation of a bottom-of-sulcus focal cortical dysplasia and a cavernous malformation(A) AMYGDALOHIPPOCAMPOTOMYamygdalahippocampal headtemporal hornoccipital entry alonghippocampal axislateral temporalneocortex (spared)(B) HYPOTHALAMIC HAMARTOMAfornixmammillothalamic tractthird ventricleattachment zone(disconnection target)mammillary bodyhamartomaoptic chiasminfundibulum / pituitary(C) CORPUS CALLOSOTOMYcingulate gyruscorpus callosum(anterior 2/3 ablated)splenium (spared;completion target)septum pellucidumfornixthalamusanterior commissure(D) LESIONAL ABLATIONFCD (bottom ofsulcus)tuber / cavernousmalformationtransmantle signSEEG-guidedwhen neededablation zone (pale rim: thermal-damage boundary)laser fiber via skull boltschematic; not to scale
LITT targets in epilepsy surgery. (A) Laser amygdalohippocampotomy: the fiber enters occipitally and runs along the long axis of the hippocampus, ablating the amygdala, hippocampal head and parahippocampal gyrus and sparing the lateral neocortex. (B) Hypothalamic hamartoma: ablation targets the attachment zone to disconnect the hamartoma from the hypothalamus. (C) Laser corpus callosotomy: fibers ablate the anterior two-thirds of the corpus callosum, with the splenium left for completion if needed. (D) Lesional ablation of a bottom-of-sulcus focal cortical dysplasia, and of a tuber or cavernous malformation, guided by SEEG when needed. Not to scale.

Overall evidence vs. open surgery

Mesial temporal lobe epilepsy and SLATE

Hypothalamic hamartoma

Corpus callosotomy

Lesional ablation

Related topics

References

  1. Gross RE, Stern MA, Willie JT, et al. Stereotactic laser amygdalohippocampotomy for mesial temporal lobe epilepsy. Ann Neurol 2018;83(3):575–587. doi:10.1002/ana.25180. PMID 29420840. verified
  2. Arocho-Quinones EV, Lew SM, Handler MH, et al. Magnetic resonance-guided stereotactic laser ablation therapy for the treatment of pediatric brain tumors: a multiinstitutional retrospective study. J Neurosurg Pediatr 2020;26(1):13–21. doi:10.3171/2020.1.PEDS19496. PMID 32217793. verified
  3. Willie JT, Malcolm JG, Stern MA, et al. Safety and effectiveness of stereotactic laser ablation for epileptogenic cerebral cavernous malformations. Epilepsia 2019;60(2):220–232. doi:10.1111/epi.14634. PMID 30653657. verified
  4. Maroufi SF, Fallahi MS, Amirkhani N, et al. Laser interstitial thermal therapy versus open resective surgery for nontumoral epilepsy: systematic review and meta-analysis of comparative studies. J Neurosurg 2026;144(4):787–798. doi:10.3171/2025.8.JNS25496. PMID 41576371. verified
  5. Yossofzai O, Stone SSD, Madsen JR, et al. Machine learning models for predicting seizure outcome after MR-guided laser interstitial thermal therapy in children. J Neurosurg Pediatr 2023;32(6):739–749. doi:10.3171/2023.8.PEDS23240. PMID 37856414. verified
  6. Lewis EC, Weil AG, Duchowny M, et al. MR-guided laser interstitial thermal therapy for pediatric drug-resistant lesional epilepsy. Epilepsia 2015;56(10):1590–1598. doi:10.1111/epi.13106. PMID 26249524. verified
  7. Drane DL, Loring DW, Voets NL, et al. Better object recognition and naming outcome with MRI-guided stereotactic laser amygdalohippocampotomy for temporal lobe epilepsy. Epilepsia 2015;56(1):101–113. doi:10.1111/epi.12860. PMID 25489630. verified
  8. Wu C, Jermakowicz WJ, Chakravorti S, et al. Effects of surgical targeting in laser interstitial thermal therapy for mesial temporal lobe epilepsy: a multicenter study of 234 patients. Epilepsia 2019;60(6):1171–1183. doi:10.1111/epi.15565. PMID 31112302. verified
  9. Youngerman BE, Banu MA, Khan F, et al. Long-term outcomes of mesial temporal laser interstitial thermal therapy for drug-resistant epilepsy and subsequent surgery for seizure recurrence: a multi-centre cohort study. J Neurol Neurosurg Psychiatry 2023;94(11):879–886. doi:10.1136/jnnp-2022-330979. PMID 37336643. verified
  10. Landazuri P, Cheng JJ, Leuthardt E, et al. Interstitial thermal therapy in mesial temporal lobe epilepsy. JAMA Neurol 2025;82(9):915–924. doi:10.1001/jamaneurol.2025.1897. PMID 40622685. verified
  11. Trivedi AM, Montenegro MA, Gonda D, et al. Laser interstitial thermal therapy for the treatment of mesial temporal lobe epilepsy in children. J Child Neurol 2025;40(5):342–347. doi:10.1177/08830738241312262. PMID 39887192. verified
  12. Sperling MR, Gross RE, Alvarez GE, et al. Stereotactic laser ablation for mesial temporal lobe epilepsy: a prospective, multicenter, single-arm study. Epilepsia 2020;61(6):1183–1189. doi:10.1111/epi.16529. PMID 32412094. verified
  13. Medtronic. Stereotactic Laser Ablation for Temporal Lobe Epilepsy (SLATE). ClinicalTrials.gov identifier NCT02844465. Results first posted 2025-01-17. (verified on ClinicalTrials.gov)
  14. Wu C, Busch RM, Drane DL, et al. Comparative review of seizure and cognitive outcomes in resective, ablative, and neuromodulatory temporal lobe epilepsy surgery. Epilepsy Curr 2025;25(5):290–296. doi:10.1177/15357597251318564. PMID 40028188. verified
  15. Niazi F, Goel K, Chen JS, et al. Outcome of surgery for hypothalamic hamartoma-related epilepsy: a systematic review and individual participant data meta-analysis. Neurology 2024;103(12):e210060. doi:10.1212/WNL.0000000000210060. PMID 39642321. verified
  16. Curry DJ, Raskin J, Ali I, Wilfong AA. MR-guided laser ablation for the treatment of hypothalamic hamartomas. Epilepsy Res 2018;142:131–134. doi:10.1016/j.eplepsyres.2018.03.013. PMID 29631919. verified
  17. Gadgil N, Lam S, Pan IW, et al. Staged magnetic resonance-guided laser interstitial thermal therapy for hypothalamic hamartoma: analysis of ablation volumes and morphological considerations. Neurosurgery 2020;86(6):808–816. doi:10.1093/neuros/nyz378. PMID 31990344. verified
  18. Merenzon MA, O'Malley G, Terry F, et al. Stereotactic laser ablation vs open corpus callosotomy: a systematic review and meta-analysis of individual patient data. Oper Neurosurg 2026;30(5):641–652. doi:10.1227/ons.0000000000001709. PMID 40719433. verified
  19. Awad AJ, Kaiser KN. Laser ablation for corpus callosotomy: systematic review and pooled analysis. Seizure 2022;96:137–141. doi:10.1016/j.seizure.2022.02.002. PMID 35245877. verified
  20. Huang Y, Yecies D, Bruckert L, et al. Stereotactic laser ablation for completion corpus callosotomy. J Neurosurg Pediatr 2019;24(4):433–441. doi:10.3171/2019.5.PEDS19117. PMID 31374542. verified
  21. Wang Y, Tai Y, Liu T, et al. Efficacy and safety of MR guided-laser interstitial thermal therapy versus resective surgery for MRI-positive focal cortical dysplasia type II and tuberous sclerosis complex: a systematic review and meta-analysis. Seizure 2026;142:121–130. doi:10.1016/j.seizure.2026.08.021. PMID 42679657. verified
  22. Ortman C, Coorg R, Ali I, et al. Clinical outcomes following stereotactic MRI-guided laser ablation in children with tuberous sclerosis complex and intractable epilepsy. Epilepsia 2026;67(3):1169–1180. doi:10.1111/epi.70036. PMID 41367165. verified
  23. Stellon MA, Cobourn K, Whitehead MT, et al. "Laser and the tuber": thermal dynamic and volumetric factors influencing seizure outcomes in pediatric subjects with tuberous sclerosis undergoing stereoencephalography-directed laser ablation of tubers. Childs Nerv Syst 2019;35(8):1333–1340. doi:10.1007/s00381-019-04255-4. PMID 31209639. verified
  24. McCormack RM, Chandran AS, Lhatoo SD, et al. Laser ablation of periventricular nodular heterotopia for medically refractory epilepsy. Ann Neurol 2024;96(6):1174–1184. doi:10.1002/ana.27059. PMID 39297387. verified

Verification (2026-11-13): each reference's authors, title, journal, volume, pages, DOI and PMID were checked on PubMed. Numbers were checked against the PubMed abstracts.

SLATE (2026-11-17):

Caveats: